SCHEMBL7214029

SCHEMBL7214029

CCOC(=O)N1CCc2ccccc2C1Cc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1B P49286 1/20 0.50
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
OPRM1 P35372 2/20 0.46
OPRK1 P41145 2/20 0.46
OPRD1 P41143 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
ALDH1A1 P00352 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
HTT P42858 1/20 0.44
PSEN1 P49768 1/20 0.44
PSEN2 P49810 1/20 0.44
APH1B Q8WW43 1/20 0.44
NCSTN Q92542 1/20 0.44
APH1A Q96BI3 1/20 0.44
PSENEN Q9NZ42 1/20 0.44
KEAP1 Q14145 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12187751 0.85 MTNR1B (0.49) MTNR1BOPRM1OPRK1OPRD1ALDH1A1
SCHEMBL28901615 0.84 MTNR1B (0.53) MTNR1BL3MBTL1KDM4EKEAP1
SCHEMBL11934342 0.82 OPRD1 (0.51) MTNR1BOPRM1OPRK1OPRD1ALDH1A1
SCHEMBL10961651 0.82 MTNR1B (0.51) MTNR1BOPRD1L3MBTL1KMT2AMEN1
SCHEMBL14375166 0.81 CHRM3 (0.49)
SCHEMBL13736195 0.81 ESR1 (0.45) CYP3A4CYP2D6CYP2C19ALDH1A1KDM4E
SCHEMBL7344341 0.81 ACE (0.61) MTNR1BALDH1A1KMT2AKDM4EMEN1
SCHEMBL4028527 0.80 NPC1 (0.54) MTNR1BCYP2C19L3MBTL1KMT2AMEN1
SCHEMBL4032811 0.80 NPC1 (0.54) MTNR1BCYP2C19L3MBTL1KMT2AMEN1
SCHEMBL13041647 0.80 CHRM3 (0.60) CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0801067-B1 NOVEL QUINUCLIDINE DERIVATIVES AND MEDICINAL COMPOSITION THEREOF YAMANOUCHI PHARMA CO LTD (JP) 2003-03-05 EP disclosed
US-6174896-B1 MUSCARINIC RECEPTOR ANTAGONISTIC ACTIVITY; FOR THERAPY AND PROPHYLAXIS FOR UROLOGIC DISEASES, RESPIRATORY DISEASES OR DIGESTIVE DISEASES YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 2001-01-16 US disclosed
US-6017927-A Quinuclidine derivatives and medicinal composition thereof YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed
EP-0801067-A1 NOVEL QUINUCLIDINE DERIVATIVES AND MEDICINAL COMPOSITION THEREOF YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1997-10-15 EP disclosed